Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.

de Bono JS, De Giorgi U, Rodrigues DN, Massard C, Bracarda S, Font A, Arranz Arija JA, Shih KC, Radavoi GD, Xu N, Chan WY, Ma H, Gendreau S, Riisnaes R, Patel PH, Maslyar DJ, Jinga V.

Clin Cancer Res. 2019 Feb 1;25(3):928-936. doi: 10.1158/1078-0432.CCR-18-0981. Epub 2018 Jul 23.

PMID:
30037818
2.

Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial.

Climent MÁ, Pérez-Valderrama B, Mellado B, Fernández Parra EM, Fernández Calvo O, Ochoa de Olza M, Muinelo Romay L, Anido U, Domenech M, Hernando Polo S, Arranz Arija JÁ, Caballero C, Juan Fita MJ, Castellano D.

Eur J Cancer. 2017 Dec;87:30-37. doi: 10.1016/j.ejca.2017.09.028. Epub 2017 Nov 2.

PMID:
29102858
3.

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.

Pérez-Valderrama B, Arranz Arija JA, Rodríguez Sánchez A, Pinto Marín A, Borrega García P, Castellano Gaunas DE, Rubio Romero G, Maximiano Alonso C, Villa Guzmán JC, Puertas Álvarez JL, Chirivella González I, Méndez Vidal MJ, Juan Fita MJ, León-Mateos L, Lázaro Quintela M, García Domínguez R, Jurado García JM, Vélez de Mendizábal E, Lambea Sorrosal JJ, García Carbonero I, González del Alba A, Suárez Rodríguez C, Jiménez Gallego P, Meana García JA, García Marrero RD, Gajate Borau P, Santander Lobera C, Molins Palau C, López Brea M, Fernández Parra EM, Reig Torras O, Basterretxea Badiola L, Vázquez Estévez S, González Larriba JL.

Ann Oncol. 2016 Apr;27(4):706-11. doi: 10.1093/annonc/mdv601. Epub 2015 Dec 9.

PMID:
26658889
4.

[Nutritional assessment and quality of life of oncology outpatients initiating treatment with tyrosine‑kinase inhibitors].

Ribed Sánchez A, Romero-Jiménez RM, Cuerda-Compes C, Higuera-Pulgar I, Carrascal-Fabian ML, Escudero-Vilaplana V, Arranz-Arija JA, García-Peris P, Sanjurjo-Sáez M.

Nutr Hosp. 2014 Nov 1;30(5):1092-100. doi: 10.3305/nh.2014.30.5.7761. Spanish.

5.

SEOM clinical guidelines for treatment of prostate cancer.

Arranz Arija JÁ, Cassinello Espinosa J, Climent Durán MÁ, Rivero Herrero F; SEOM (Spanish Society of Clinical Oncology).

Clin Transl Oncol. 2012 Jul;14(7):520-7.

PMID:
22721797
6.

[Mediastinal germ-cell tumours].

Díaz Muñoz de la Espada VM, Khosravi Shahi P, Hernández Marín B, Encinas García S, Arranz Arija JA, Pérez-Manga G.

An Med Interna. 2008 May;25(5):241-3. Review. Spanish.

7.

False-positive beta-human chorionic gonadotropin values in the follow-up of gestational trophoblastic disease.

Díaz Muñoz de la Espada VM, Arranz Arija JA, Khosravi Shahi P, Encinas García S, Alvarez Alvarez R, González Beca R.

Clin Transl Oncol. 2007 May;9(5):332-4.

PMID:
17525045
8.

[Effectivity of thalidomide and dexamethasone for the treatment of refractory multiple myeloma: a retrospective study of 36 consecutive cases].

Khosravi Shahi P, Díaz Muñoz de la Espada VM, Sabin Domínguez P, Encinas García S, Arranz Arija JA, Carrión Galindo JR, Pérez Manga G.

Med Clin (Barc). 2007 Feb 3;128(4):121-4. Spanish.

PMID:
17288931
9.

E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience.

Arranz Arija JA, García del Muro X, Gumà J, Aparicio J, Salazar R, Saenz A, Carles J, Sánchez M, Germà-Lluch JR.

Ann Oncol. 2001 Apr;12(4):487-91.

PMID:
11398880
10.

[Primary large cell thyroid lymphoma. Report of 6 cases treated with chemotherapy].

García Arroyo R, Carrión Galindo R, Arranz Arija JA, González San Segundo C, Martín Fragueiro L, Flores Sañudo E.

Med Clin (Barc). 1994 Jun 25;103(4):136-9. Spanish.

PMID:
8072328
11.

Primary renal lymphoma: report of 3 cases and review of the literature.

Arranz Arija JA, Carrion JR, Garcia FR, Tejedor A, Pérez-Manga G, Tardio J, Menarguez FJ.

Am J Nephrol. 1994;14(2):148-53. Review.

PMID:
8080008
12.

[Chemotherapy in prostatic carcinoma].

Pérez Manga G, Arranz Arija JA, García Gómez R, Salinas Hernández P, González del Val R.

Arch Esp Urol. 1993 Mar;46(2):116-26. Review. Spanish.

PMID:
8498851

Supplemental Content

Loading ...
Support Center